Patents by Inventor Donna Livant

Donna Livant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for, and methods of, treating cancer and inhibiting invasion and metastases
    Patent number: 8940701
    Abstract: Invasion-inhibiting peptides comprising either a modified cysteine (where the sulfur atom is modified with a alkyl group or other suitable group), and/or b) D-amino acids, for the treatment “cancer” in humans and animals. Such peptides can be used together with other therapies (e.g. radiation) to enhance the therapeutic benefit and reduce invasiveness.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: January 27, 2015
    Assignee: The Regents of the University of Michigan
    Inventor: Donna Livant
  • Compounds For, and Methods of, Treating Cancer and Inhibiting Invasion and Metastases
    Publication number: 20120077755
    Abstract: Invasion-inhibiting peptides comprising either a modified cysteine (where the sulfur atom is modified with a alkyl group or other suitable group), and/or b) D-amino acids, for the treatment “cancer” in humans and animals. Such peptides can be used together with other therapies (e.g. radiation) to enhance the therapeutic benefit and reduce invasiveness.
    Type: Application
    Filed: May 12, 2010
    Publication date: March 29, 2012
    Inventor: Donna Livant
  • Wound Healing Compounds And Methods
    Publication number: 20100292173
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Application
    Filed: May 10, 2010
    Publication date: November 18, 2010
    Inventor: Donna Livant
  • Anticancer compounds and methods
    Publication number: 20090075905
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Application
    Filed: December 7, 2006
    Publication date: March 19, 2009
    Inventor: Donna Livant
  • Anticancer compounds and methods
    Patent number: 7148196
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Grant
    Filed: September 9, 2002
    Date of Patent: December 12, 2006
    Assignee: The Regents of the University of Michigan
    Inventor: Donna Livant
  • Anticancer compounds and methods
    Publication number: 20060078535
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Application
    Filed: October 13, 2004
    Publication date: April 13, 2006
    Applicant: The Regents of the University of Michigan
    Inventor: Donna Livant
  • Anticancer compounds and methods
    Publication number: 20030083264
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Application
    Filed: September 9, 2002
    Publication date: May 1, 2003
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventor: Donna Livant
  • Anticancer compounds and methods
    Patent number: 6472369
    Abstract: The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: October 29, 2002
    Assignee: The Regents of the University of Michigan
    Inventor: Donna Livant